Purchase Order 75D30119P04179
- Not listed
- This is a $149,550 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Nanostring Technologies, Inc., a publicly traded manufacturer of genomic analysis platforms and life science tools. The contract is for the provision of Nanostring's nCounter Profiler system, which enables multiplexed digital detection and counting of nucleic acids, proteins, and cells. This award was not set aside for any specific business category. Nanostring Technologies has...
- This is a $59,600 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Nanostring Technologies, Inc. for laboratory maintenance services. The contract has an ultimate completion date of April 9, 2023 and does not use a set-aside designation. Nanostring Technologies is a publicly traded manufacturer of life science tools, including instruments, consumables, and services for genomic, molecular, and cellular analysis. The company has an extensive...
- This is a firm-fixed price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Nanostring Technologies, Inc., a publicly held manufacturer of life science tools for translational research and molecular diagnostics. The $121,000.00 contract is for a service agreement to provide the agency with Nanostring's nCounter and Digital Analyzer platforms, which enable multiplexed, digital detection and counting of nucleic acids,...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' Centers for Disease Control and Prevention to Nanostring Technologies, Inc., a publicly traded manufacturer of life science tools. The contract is for the delivery of Nanostring's nCounter MAX Analysis System, a proprietary platform for multiplexed, digital detection and counting of nucleic acids, proteins, and cells. The potential value of the contract is $236,000.00, with a completion...
- This $93,359 firm fixed-price purchase order was awarded to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools, by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract is for the delivery of Nanostring's proprietary nCounter and GeoMx analysis systems, reagents, and consumables to support genomic, molecular, and cellular...
- This federal contract award to Nanostring Technologies, Inc. is for $186,000.00 and was issued by the Office of the Director, a civilian agency. The contract is a purchase order with a firm fixed price and an ultimate completion date of August 30, 2015. Nanostring, a publicly traded provider of advanced genomic analysis platforms and life science tools, has supplied specialized laboratory equipment, reagents, assays, and testing services to support biomedical research and healthcare programs...
- This $16,420 firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools for translational research and molecular diagnostics. The contract is not set aside for any specific business type. Under this award, Nanostring will deliver specialized laboratory equipment, reagents, assays, and testing services to support genomic, molecular,...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to Nanostring Technologies, Inc., a for-profit manufacturer, to provide a NCOUNTER SPRINT PROFILER. The $149,000.00 contract, which has no set-aside designation, was awarded on September 13, 2021 with a completion date of September 30, 2021. Nanostring Technologies, a publicly held provider of life science tools, has a history of delivering specialized laboratory...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools. The $50,203.50 firm fixed-price purchase order is for the delivery of Nanostring's specialized laboratory equipment, reagents, assays, and testing services to support genomic, molecular, and...
- This is a $127,500 firm fixed-price Purchase Order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Nanostring Technologies, Inc. for the NanoString nCounter Analysis System. The contract does not have a set-aside designation. Nanostring Technologies is a publicly traded provider of advanced genomic analysis platforms and life science tools. Through this contract, they are supplying specialized laboratory equipment, reagents, assays,...
This $95,320 firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools. The contract is for the delivery of "GENE SETS", with an ultimate completion date of March 30, 2019. Nanostring is a manufacturer of goods and has provided a wide range of products and services to various federal agencies through past prime and subcontract awards. These include specialized laboratory equipment, reagents, assays, and testing services to support genomic, molecular, and cellular analysis for biomedical research and healthcare programs. Nanostring also holds two significant federal contract IDVs, one with the USDA Agricultural Research Service and another with the Defense Health Agency, valued at $596,881.45 and $2.8 million respectively. This particular award was not set aside for any specific business type.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $95.3k | 3/25/19 |